Intel sets up dedicated digital health unit:
This article was originally published in Clinica
Computer chip giant Intel has created a new business unit focused on digital health as part of a company reorganisation. The division, to be led by Louis Burns, "will develop products and explore business opportunities for Intel architecture products in healthcare research, diagnostics and productivity, as well as personal healthcare", said Intel. The Santa Clara, California-based group wants to emphasise its capabilities in "platforms" containing "full sets of technology ingredients", thus moving away from its traditional reliance on marketing components individually.
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.